Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $174,000 - $280,500
-15,000 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$18.95 - $28.08 $53,060 - $78,624
-2,800 Reduced 15.73%
15,000 $303,000
Q2 2018

Aug 14, 2018

BUY
$20.0 - $29.72 $90,000 - $133,740
4,500 Added 33.83%
17,800 $421,000
Q1 2018

May 15, 2018

BUY
$21.69 - $32.99 $288,477 - $438,767
13,300 New
13,300 $300,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.7B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.